|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) |
| (11) | Number of the document | 2744826 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12745883.4 |
| Date of filing the European patent application | 2012-08-14 | |
| (97) | Date of publication of the European application | 2014-06-25 |
| (45) | Date of publication and mention of the grant of the patent | 2022-02-09 |
| (46) | Date of publication of the claims translation | 2022-04-25 |
| (86) | Number | PCT/EP2012/065904 |
| Date | 2012-08-14 |
| (87) | Number | WO 2013/024095 |
| Date | 2013-02-21 |
| (30) | Number | Date | Country code |
| 11177660 | 2011-08-16 | EP | |
| 201161523862 P | 2011-08-16 | US |
| (72) |
AMERSDORFFER, Jutta , DE
STEIDL, Stefan , DE
WINDERLICH, Mark , DE
KROHN, Susanne , DE
ROJKJAER, Lisa , CH
|
| (73) |
Incyte Corporation ,
1801 Augustine Cut-Off, Wilmington, Delaware 19803,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kombinuota terapija su anti-CD19 antikūnu ir purino analogu |
| COMBINATION THERAPY WITH AN ANTI-CD19 ANTIBODY AND A PURINE ANALOG |
| Payment date | Validity (years) | Amount | |
| 2025-08-08 | 14 | 289.00 EUR |
| 2026-08-14 |